Risk of recurrent venous thromboembolism and bleeding with apixaban versus rivaroxaban: an analysis of real-world data

被引：0
|
作者：
Villoing, B. [1 ]
机构：
[1] Ctr Hosp Cochin, AP HP, Hotel Dieu, Urgences SMUR, F-75014 Paris, France
来源：
ANNALES FRANCAISES DE MEDECINE D URGENCE | 2022年 / 12卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：131 / 131
页数：1
相关论文
共 50 条
  • [1] Risk for Recurrent Venous Thromboembolism and Bleeding With Apixaban Compared With Rivaroxaban: An Analysis of Real-World Data
    Dawwas, Ghadeer K.
    Leonard, Charles E.
    Lewis, James D.
    Cuker, Adam
    [J]. ANNALS OF INTERNAL MEDICINE, 2022, 175 (01) : 20 - +
  • [2] The Real World Experience Regarding the Safety of Rivaroxaban and Apixaban in Venous Thromboembolism Patients with High Bleeding Risk
    Ouyang, Haoxu
    Khillan, Ratesh
    Yu, Nyein Htway
    Preet, Mohan
    [J]. BLOOD, 2019, 134
  • [3] Risk factors for recurrent venous thromboembolism: a real-world analysis
    Fu, Alex Z.
    Feng, Xue
    Ashton, Veronica
    Kharat, Akshay
    [J]. BLOOD COAGULATION & FIBRINOLYSIS, 2022, 33 (06) : 301 - 309
  • [4] Utility of Rivaroxaban for Real-World Patients With Venous Thromboembolism
    Yamashita, Yugo
    [J]. CIRCULATION JOURNAL, 2023, 87 (09) : 1185 - 1186
  • [5] Apixaban for Treating Venous Thromboembolism in Real-World Clinical Practice
    Monreal, Manuel
    [J]. THROMBOSIS AND HAEMOSTASIS, 2018, 118 (11) : 1850 - 1851
  • [6] Effectiveness and safety of apixaban versus rivaroxaban for prevention of recurrent venous thromboembolism and adverse bleeding events in patients with venous thromboembolism: a retrospective population-based cohort analysis
    Dawwas, Ghadeer K.
    Brown, Joshua
    Dietrich, Eric
    Park, Haesuk
    [J]. LANCET HAEMATOLOGY, 2019, 6 (01): : E20 - E28
  • [7] Comparative effectiveness of apixaban versus rivaroxaban for the prevention of cardiovascular diseases and recurrent venous thromboembolism
    Dawwas, Ghadeer
    Park, Haesuk
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 35 - 35
  • [8] Rivaroxaban and apixaban in patients with atrial fibrillation; a real-world data
    Aslan, Onur
    Yildirim, Sinan
    [J]. TURKISH JOURNAL OF MEDICAL SCIENCES, 2022, 52 (04) : 948 - 957
  • [9] The comparative effectiveness and safety of warfarin, rivaroxaban, and apixaban in patients with venous thromboembolism: An analysis of three real-world US healthcare databases
    Iyer, Geetha
    Tesfaye, Helen
    Brill, Gregory
    Zakoul, Heidi
    Schneeweiss, Sebastian
    Bykov, Katsiaryna
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 11 - 12
  • [10] Effectiveness and Safety of Nonvitamin K Oral Anticoagulants Rivaroxaban and Apixaban in Patients with Venous Thromboembolism: A Meta-Analysis of Real-World Studies
    Wu, Olivia
    Morris, Stephen
    Larsen, Torben Bjerregaard
    Skjoth, Flemming
    Evans, Alex
    Bowrin, Kevin
    Wojciechowski, Piotr
    Margas, Wojciech
    Huelsebeck, Maria
    [J]. CARDIOVASCULAR THERAPEUTICS, 2022, 2022
12345